Key result
Development of DVT within one month after major orthopedic surgery was associated with a 22% and 74% increase in outpatient and emergency department visits, respectively, and over $2000 in added costs.
Why the study?
Does the development of DVT following major orthopedic surgery increase healthcare costs and resource utilization in adult patients?
Cohort (n=32,899)
Does the development of DVT following major orthopedic surgery increase healthcare costs and resource utilization in adult patients?
The development of DVT following major orthopedic surgery is associated with significantly increased healthcare resource utilization and costs over a 6-month postdischarge period.
Answers are grounded in this paper and cite their sources.
May heighten postdischarge burden after orthopedic surgery; extends observational cost data but leaves causal prevention effects open.
BACKGROUND: Venous thromboembolism (VTE) is a known complication of major orthopedic surgery (MOS) with important clinical and economic consequences. Recently published orthopedic guidelines have focused on prevention of pulmonary embolism as a primary outcome, but deep vein thrombosis (DVT) occurrence should not be readily dismissed. OBJECTIVE: To describe the burden of DVT following hospital discharge for MOS by assessing the impact of DVT on costs and resource utilization from the third-party payer perspective. METHODS: Retrospective analysis used outpatient medical and pharmacy data from the PharMetrics Patient-Centric Database (January 1, 2002-March 31, 2006). Patients 18 years of age or older with a record of MOS were eligible for inclusion. Included patients were stratified based on the presence of a DVT during the first month after hospital discharge. Characteristics of the samples were described. The impact of DVT on total 6-month costs and resource utilization (readmissions, outpatient, emergency department visits) was assessed through statistical models. RESULTS: Of the 32,899 patients in the analysis, 1221 (3.71%) had a record of DVT during the first month following discharge for MOS. Compared with patients who did not develop DVT, patients who developed DVT postdischarge were slightly older (56.5 vs 55.8 y; p = 0.0127), had a higher occurrence of prior VTE (26.2% vs 3.4%; p < 0.0001), and had undergone recent surgical procedures other than MOS (73.0% vs 69.6%; p = 0.0116). After controlling for potential confounders, DVT was associated with a 22% and 74% increase in the average number of expected outpatient and emergency department visits, respectively, during the 6-month postdischarge period but did not significantly impact the number of readmissions. Furthermore, total 6-month costs were significantly higher for patients who developed DVT, with an incremental increase of over $2000. CONCLUSIONS: The burden of DVT following hospital discharge for MOS is substantial. Specifically, DVT increases total costs and outpatient and emergency department visits.
No takes yet. Share an insight, caveat, or question.
Nutescu et al. (2008) conducted a cohort in Major orthopedic surgery (n=32,899). Deep vein thrombosis (DVT) during the first month after hospital discharge vs. No DVT during the first month after hospital discharge was evaluated on Total 6-month costs and resource utilization (readmissions, outpatient, emergency department visits). Development of DVT within one month after major orthopedic surgery was associated with a 22% and 74% increase in outpatient and emergency department visits, respectively, and over $2000 in added costs.
Synapse has enriched 10 related papers. Consider them for comparative context: